Analysis of E2 gene integrity in HPV16 and HPV58 viruses isolated from women with cervical pathology

Mem Inst Oswaldo Cruz. 2016 Dec;111(12):770-773. doi: 10.1590/0074-02760160269. Epub 2016 Oct 31.

Abstract

Integration of human papillomavirus (HPV) DNA into human cells accompanied by the disruption of the viral genome has been described as a prerequisite for cancer development. This study aimed to investigate E2 gene integrity of HPV16 and HPV58 viruses isolated from infected women with cervical lesions. Forty-two HPV16- and 31 HPV58-positive samples were analysed. E2 integrity was assumed when all fragments covering the E2 gene were amplified with specific polymerase chain reaction primers. Overall, in 59% of the samples, at least one fragment was not amplified in HPV16- (57%) and HPV58-positive samples (61%). Samples from high-grade squamous intraepithelial lesions had the highest frequency of E2 gene disruptions (73%), followed by samples from low-grade squamous intraepithelial lesions (63%) and, finally, samples from invasive cervical cancer (35%). Association between the integrity status of the E2 gene, and lesion grade was assessed by the chi-squared test applied to the combined set of viruses (p = 0.6555) or to populations of the same virus type (HPV58, p = 0.3101; HPV16, p = 0.3024). In conclusion, in this study, no association was found between the presence of E2 gene disruptions and the grade of cervical lesions caused by HPV16 and HPV58.

MeSH terms

  • Carcinoma, Squamous Cell / virology*
  • Cross-Sectional Studies
  • DNA, Viral / genetics
  • DNA-Binding Proteins / genetics*
  • Female
  • Human papillomavirus 16 / genetics*
  • Humans
  • Oncogene Proteins, Viral / genetics*
  • Papillomavirus Infections / complications
  • Papillomavirus Infections / virology*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Uterine Cervical Dysplasia / virology*
  • Uterine Cervical Neoplasms / virology*

Substances

  • DNA, Viral
  • DNA-Binding Proteins
  • E2 protein, Human papillomavirus type 16
  • Oncogene Proteins, Viral